These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9160657)

  • 1. A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
    Rumi MG; Santagostino E; Morfini M; Gringeri A; Tagariello G; Chistolini A; Pontisso P; Tagger A; Colombo M; Mannucci PM
    Blood; 1997 May; 89(10):3529-33. PubMed ID: 9160657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response.
    Hanley JP; Jarvis LM; Andrew J; Dennis R; Hayes PC; Piris J; Lee R; Simmonds P; Ludlam CA
    Blood; 1996 Mar; 87(5):1704-9. PubMed ID: 8634415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
    Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
    Blood; 1991 Oct; 78(7):1672-7. PubMed ID: 1912556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
    Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN
    J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
    Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.
    Berg T; Dirla U; Naumann U; Heuft HG; Küther S; Lobeck H; Schreier E; Hopf U
    J Hepatol; 1996 Nov; 25(5):763-8. PubMed ID: 8938557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
    Sauleda S; Esteban JI; Altisent C; Puig L; Esteban R; Guardia J
    Thromb Haemost; 2000 Jun; 83(6):807-10. PubMed ID: 10896229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
    Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Isobe K; Takamatsu J; Imoto M; Hayakawa T
    Eur J Haematol; 1996 Aug; 57(2):165-70. PubMed ID: 8856094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY
    Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.
    Vandelli C; Renzo F; Braun HB; Tisminetzky S; Albrecht M; De Palma M; Ranzi A; Di Marco G; Stroffolini T; Baralle F; Ventura E; Michel G
    J Med Virol; 1999 May; 58(1):26-34. PubMed ID: 10223542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.